Literature DB >> 31414117

Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus.

Janine M Trevillyan1,2, Carlee Moser3, Judith S Currier1, Tamer Sallam4.   

Abstract

In a retrospective case control analysis, following adjustments for high-sensitivity C-reactive protein (hsCRP), traditional cardiovascular risk factors, and the CD4/CD8 T-cell ratio, higher lipopolysaccharide-binding protein (LBP) was associated with future myocardial infarctions in hsCRP human immunodeficiency virus (HIV). LBP may be a marker of cardiovascular risk with utility in HIV.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; acute myocardial infarction; cardiovascular disease; immune activation; inflammation

Year:  2020        PMID： 31414117      PMCID： PMC7346757          DOI： 10.1093/cid/ciz765

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

2.  Lipopolysaccharide-binding protein (LBP) is associated with total and cardiovascular mortality in individuals with or without stable coronary artery disease--results from the Ludwigshafen Risk and Cardiovascular Health Study (LURIC).

Authors:  Philipp M Lepper; Marcus E Kleber; Tanja B Grammer; Kristina Hoffmann; Simone Dietz; Bernhard R Winkelmann; Bernhard O Boehm; Winfried März
Journal:  Atherosclerosis       Date:  2011-06-13       Impact factor: 5.162

Review 3.  The role of lipopolysaccharide-binding protein in innate immunity: a revisit and its relevance to oral/periodontal health.

Authors:  P-H Ding; L J Jin
Journal:  J Periodontal Res       Date:  2013-04-18       Impact factor: 4.419

Review 4.  Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.

Authors:  Matthew J Feinstein; Priscilla Y Hsue; Laura A Benjamin; Gerald S Bloomfield; Judith S Currier; Matthew S Freiberg; Steven K Grinspoon; Jules Levin; Chris T Longenecker; Wendy S Post
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690

5.  Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.

Authors:  Jacqueline Neuhaus; David R Jacobs; Jason V Baker; Alexandra Calmy; Daniel Duprez; Alberto La Rosa; Lewis H Kuller; Sarah L Pett; Matti Ristola; Michael J Ross; Michael G Shlipak; Russell Tracy; James D Neaton
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

6.  The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis.

Authors:  Tamer Sallam; Ayaka Ito; Xin Rong; Jason Kim; Caroline van Stijn; Brian T Chamberlain; Michael E Jung; Lily C Chao; Marius Jones; Thomas Gilliland; XiaoHui Wu; Grace L Su; Rajendra K Tangirala; Peter Tontonoz; Cynthia Hong
Journal:  J Lipid Res       Date:  2014-03-26       Impact factor: 5.922

Review 7.  Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.

Authors:  Gregor F Lichtfuss; Jennifer Hoy; Reena Rajasuriar; Marit Kramski; Suzanne M Crowe; Sharon R Lewin
Journal:  Biomark Med       Date:  2011-04       Impact factor: 2.851

Review 8.  Liver X receptor in cholesterol metabolism.

Authors:  Chunyan Zhao; Karin Dahlman-Wright
Journal:  J Endocrinol       Date:  2009-10-16       Impact factor: 4.286

9.  Association of lipopolysaccharide-binding protein and coronary artery disease in men.

Authors:  Philipp M Lepper; Christian Schumann; Kathy Triantafilou; F Maximilian Rasche; Tibor Schuster; Hedwig Frank; E Marion Schneider; Martha Triantafilou; Maximilian von Eynatten
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094

10.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.